Analysed CLEARMIND MEDICINE INC (CMND:NASDAQ) News Sources
Clearmind Medicine Advances Its Innovation with Newly Granted U.S. Patent, Enhancing Global Patent Strength
29-06-2026
yahoo.com
Clearmind Reports Successful Formulation Feasibility Study Supporting Potential New Additional Route of Administration Development for MEAI
07-07-2026
yahoo.com
Clearmind Medicine Responds to the U.S. Administration’s RFI for Addiction Treatment Innovations as Part of the Great American Recovery Initiative
10-07-2026
yahoo.com
Clearmind Shares Promising Real-World Insights from Ongoing CMND-100 First-in-Human Trial
13-07-2026
yahoo.com
Clearmind Medicine Reports Positive Retention Results for Intranasal Formulation of its Psychedelic-Based Neuroplastogen MEAI
16-07-2026
yahoo.com
Clearmind Medicine Commends Federal Momentum in Advancing Psychedelic-Based Therapies for Mental Health and Addiction
17-07-2026
yahoo.com
Clearmind Medicine Expends Global IP portfolio with Hong Kong Patent Filing for Novel Psychedelic Compounds; Targets Multi‑Billion‑Dollar PTSD Therapeutics Market
20-07-2026
yahoo.com
Clearmind Medicine Successfully Completes Part A of its FDA Regulated Phase I/II Trial
28-07-2026
yahoo.com
What is the current price of CLEARMIND MEDICINE INC (CMND:NASDAQ)?
The current price of CLEARMIND MEDICINE INC (CMND:NASDAQ) is $1.69.
CLEARMIND MEDICINE INC (CMND:NASDAQ) absolute price change since previous trading day?
The absolute price change of CLEARMIND MEDICINE INC (CMND:NASDAQ) since the previous trading day is $0.07.
CLEARMIND MEDICINE INC (CMND:NASDAQ) percentage price change since previous trading day?
The percentage price change of CLEARMIND MEDICINE INC (CMND:NASDAQ) since the previous trading day is 4.321%.
What is the most recent average sentiment score for CLEARMIND MEDICINE INC (CMND:NASDAQ)?
The most recent average sentiment score for CLEARMIND MEDICINE INC (CMND:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for CLEARMIND MEDICINE INC (CMND:NASDAQ)?
The most recent sentiment for CLEARMIND MEDICINE INC (CMND:NASDAQ) is .
SEC-8K** Filing Available For CLEARMIND MEDICINE INC (CMND:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.